Tag: biotechnology
-
Enrollment Completed in Aging Frailty Stem Cell Trial
A company developing stem cell treatments to counter frailty in older people finished enlisting participants in a clinical trial testing its therapies.
-
Engineered Bacteria Deliver Cancer Immunotherapy
13 Feb. 2020. A biomedical engineering team designed probiotic bacteria, which in lab mice are shown to deliver and enhance cancer immunotherapy drugs. Researchers at Columbia University in New York describe their engineered bacteria and findings in yesterday’s issue of the journal Science Translational Medicine (paid subscription required). Treatments that invoke the immune system to…
-
Janssen, BARDA Partner on Coronavirus Vaccine
An industry-government collaboration aims to advance and produce vaccines against the 2019 novel coronavirus outbreak in China and elsewhere.
-
Nasal Spray Reduces Migraine-Related Stress, Peptides
A hormone resembling insulin given as a nasal spray is shown in lab rats to reduce stress on nerve cells and peptides associated with migraine pain.
-
Gene Therapy Licensed for Multiple Aging Diseases
A university spin-off company developing treatments to extend the lifetimes of dogs is gaining a gene therapy for preventing multiple age-related diseases.
-
Blood Cancers Respond to Cord Blood Cells
A small-scale clinical trial shows most patients with two blood-related cancers safely respond to immune system cells derived from umbilical cord blood.
-
Companies Deploy Blockchain for Food Safety, Tracking
A company offering food and animal safety services is applying blockchain technologies to boost its livestock and food tracking capabilities.
-
Intl Group Calls for More Coronavirus Vaccines
An international consortium issued a proposal call for more vaccines to protect against the novel coronavirus now spreading from China to the rest of the world.
-
FDA Approves Children’s Peanut Allergy Drug
The U.S. Food and Drug Administration on Friday approved the first treatment for children to reduce severe allergic reactions to peanuts.
-
Crispr Company Raises $45M in Venture Funds
A spin-off enterprise from a pioneering Crispr research lab is raising $45 million in venture funds to develop diagnostics and other applications.